RESEARCH TRIANGLE PARK – A flood of quarterly earnings for North Carolina public companies continues with Vontier, AvidXchange, Fennec, G1 Therapeutics, Enact, Verona reporting.
Here are links to their announcements:
- Vontier: https://www.businesswire.com/news/home/20230803075941/en/Vontier-Reports-Strong-Second-Quarter-2023-Results-and-Raises-Full-Year-Guidance
- AvidXchange: https://ir.avidxchange.com/news-releases/news-release-details/avidxchange-announces-second-quarter-2023-financial-results
- Fennec Pharmaceuticals: https://www.globenewswire.com/news-release/2023/08/03/2717728/0/en/Fennec-Pharmaceuticals-Announces-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
- G1 Therapeutics: https://www.globenewswire.com/news-release/2023/08/02/2716638/0/en/G1-Therapeutics-Provides-Second-Quarter-2023-Financial-Results-and-Operational-Highlights.html
- Enact: https://www.globenewswire.com/news-release/2023/08/01/2716425/0/en/Enact-Reports-Second-Quarter-2023-Results.html
- Verona Pharma: https://www.globenewswire.com/news-release/2023/08/03/2717625/0/en/Verona-Pharma-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
